FDA Issues Warning on Dangers of Libation Therapy
The U.S. Food and Drug Administration is warning about injuries and death associated with the use of an experimental procedure often called “libation therapy ” or “liberation procedure ” to treat chronic cerebrospinal venous insufficiency